Home » Topics » BioWorld Science

BioWorld Science
RSS

MeNZB meningococcal B vaccine approved in New Zealand

July 9, 2004

Abbott and Celera form cancer therapeutics collaboration

July 9, 2004

DOV reaches agreement with FDA on clinical trial program for DOV diltiazem

July 9, 2004

GOG submits IND for Xyotax study in ovarian cancer

July 9, 2004

New oxymorphone ER trial protocol agreed under SPA

July 9, 2004

Icatibant awarded orphan drug status for edema in severe burn patients

July 9, 2004

U.S. phase I trial of Exherin cleared to begin

July 9, 2004

End-of-phase II meeting held for HspE7

July 9, 2004

trans-ISA-247 completes single ascending dose study

July 9, 2004

Chiron acquires Sagres Discovery

July 9, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 30, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Regulatory actions for July 27, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Alfasigma,...